Impact of Innate Immunity, Endothelial Damage, and Metabolic Biomarkers on COVID-19 Severity and Mortality
Year: 2022
Type: article
Abstract: In this study, abnormal levels of myeloid activation, endothelial damage, and innate immune markers were associated with severe coronavirus disease 2019 (COVID-19), while higher levels of metabolic biomarkers (irisin, leptin) demonstrated a protective effect. These data support a model for COVID-19 immunopathogenesis linking robust inflammation and endothelial damage in metabolically predisposed individuals.
Source: Open Forum Infectious Diseases
DOI: 10.1093/ofid/ofac427
Institutions: National Institutes of Health, National Institute of Allergy and Infectious Diseases, Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari, University of Bari Aldo Moro, University of Foggia, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc. (United States), National Institute of Dental and Craniofacial Research
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,676
OpenAlex ID: W4292440787
